Shilpa CDMO, the complex chemistry CDMO, is investing $50 million to expand its peptide manufacturing capabilities as global demand accelerates for GLP-1s and a new generation of more complex
1nhaler, a Scotland-based drug delivery device developer, has secured £2.2 million in follow-on funding to progress its novel pop-up cardboard inhaler towards first regulatory approval.
The
A UK start-up, whose powder transfer valve "solves some of the key challenges facing pharmaceutical manufacturers", has raised over £2.4m to commercialise its technology.
Ross Turnbull, director of business development at ASIC design and supply specialist Swindon Silicon Systems, explains why the silicon behind sensors matters as much as the investment itself.
Hansa Biopharma and SERB S.A. has announced required regulatory approvals have been obtained and that the previously announced exclusive licensing transaction with SERB has closed.
Corten Capital and Ampersand Capital Partners (“Ampersand”) have announced the completion of their acquisition of Beacon Intelligence from the Hanson Wade Group, backed by Graphite Capital.
NunaBio, a next-gen DNA manufacturing company, has secured £6.5 million in funding to scale-up its DNA platform and accelerate its continued growth as a commercially focused infrastructure business for synthetic biology, therapeutics, and research.
Daikin Rental Solutions has announced an expansion of its fleet, combining new high-capacity cooling systems, low-carbon heating solutions, process cooling equipment, and UK-manufactured air handling units to meet growing demand for HVAC.
Axplora has announced a major milestone in its $60 million investment programme in highly potent API (HPAPI) manufacturing at its Farmabios site in Gropello Cairoli.
A new UK-based consortium, led by Exactmer, with support from GSK, has been awarded over £7 million in funding from Innovate UK in partnership with the DHSC, to advance the production of high purity bio-based solvents for medicines manufacturing.